CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma

Histopathology

Volumn 43, Issue 2, 2003, Pages 144-150

  McCluggage, W G ^a,d   Oliva, E ^b   Herrington, C S ^c   McBride, H ^a   Young, R H ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL GROUP OF HOSPITALS   (United Kingdom)

Author keywords

Adenocarcinoma; Calretinin; CD10; Cervix; Immunohistochemistry; Mesonephric lesions; Uterus

Indexed keywords

ANTIBODY; CALRETININ; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ADENOCARCINOMA; ANTIBODY SPECIFICITY; ARTICLE; CELL NUCLEUS; CYTOPLASM; ENDOMETRIOID CARCINOMA; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESONEPHROMA; METAPLASIA; PRIORITY JOURNAL; TUBO ENDOMETRIAL METAPLASIA; UTERINE CERVIX TUMOR; UTERUS CANCER;

CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOMA, ENDOMETRIOID; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MESONEPHROS; NEPRILYSIN; SENSITIVITY AND SPECIFICITY; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042660993     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01684.x     Document Type: Article

References (29)

1. Greaves MG, Hariri G, Newman RA et al. Selective expression of the common acute lymphoblastic leukaemia (gp100) antigen on immature lymphoid cells and their malignant counterparts. Blood 1983: 61; 628-629.
2. McCluggage WG, Catherwood M, Alexander HD, McBride HA, Smith MEF, Morris TCM. Immunohistochemical expression of CD10 and t(14:18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma. Histopathology 2002: 41; 414-420.
3. Stein H, Lennert K, Feller AC et al. Immunohistochemical analysis of human lymphoma: correlation of histological and immunological categories. Adv. Cancer Res. 1984: 42; 67-147.
4. Weiss LM, Bindl JM, Picozzi VJ et al. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukaemia. Blood 1986: 61; 474-478.
5. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000: 24; 203-210.
6. Borscheri N, Roessner A, Rocken C. Canalicular immunostaining of nephrilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am. J. Surg. Pathol. 2001: 25; 1297-1303.
7. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am. J. Clin. Pathol. 2000: 113; 374-382.
8. Mahenderan R, McIlhinney R, O'Hare M et al. Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breast. Mol. Cell Probes 1989: 3; 39-44.
9. Yang B, Ali SZ, Rosenthal DC. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration. Diagn. Cytopathol. 2002: 27; 149-152.
10. Agoff SN, Grieco VS, Garcia R, Gown AM. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl. Immuno. Mol Morph. 2001: 9; 164-169.
11. Chu PG, Arber PA, Weiss LM et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod. Pathol. 2001: 14; 465-471.
12. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001: 39; 273-278.
13. Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasising the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am. J. Surg. Pathol. 2002: 26; 403-412.
14. Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int. J. Gynecol. Pathol. 2002: 21; 41-47.
15. Sumathi VP, McCluggage WG. CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J. Clin. Pathol. 2002: 55; 391-392.
16. Afify AM, Tan LC, Werness BA. The diagnostic utility of CD10 in evaluating endometrial lesions. (Abstract) Mod. Pathol. 2002: 15; 189A.
17. Nascimento AF, Hirsh MS, Cviko A et al. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod. Pathol. 2003: 16; 22-27.
18. Sroden M, Klein WM, Kurman RJ. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am. J. Surg. Pathol. 2003: 27; 786-789.
19. Ordi J, Nogales FF, Palacia A et al. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am. J. Surg. Pathol. 2001: 25; 1540-1545.
20. Doglioni C, Dei Tos AP, Laurino L. Calretinin: a novel immunocytochemical marker for mesothelioma. Am. J. Surg. Pathol. 1996: 20; 1037-1046.
21. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis and ovarian sex cord-stromal tumors. Int. J. Gynecol. Pathol. 2001: 20; 346-352.
22. McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology 2001: 38; 403-408.
23. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA, Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum. Pathol. 1999: 30; 856-863.
24. Silver SA, Devouassoux-Shisheboran M, Mezzetti TP, Tavassoli FA. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings. Am. J. Surg. Pathol. 2001: 25; 379-387.
25. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002: 41; 185-207.
26. Erdos EG, Schulz WW, Gafford JT et al. Neutral metalloendopeptidase in human male genital tract: comparison to angiotensin I-converting enzyme. Lab. Invest. 1985: 52; 437-447.
27. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia and neoplasia of the uterine cervix: a study of 49 cases. Am. J. Surg. Pathol. 1990: 14; 1100-1111.
28. Seidman JD, Tavassoli FA. Mesonephric hyperplasia of the uterine cervix. A clinicopathologic study of 51 cases. Int. J. Gynecol. Pathol. 1995: 14; 293-299.
29. Clement PB, Young RH, Keh P, Ostor AG, Scully RE. Malignant mesonephric neoplasms of the uterine cervix - a report of eight cases, including four with a malignant spindle cell component. Am. J. Surg. Pathol. 1995: 19; 1158-1171.